SCHEMBL4893652

SCHEMBL4893652

CC(=O)/C=C/c1cnn(C)c1C

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.63
HPGD P15428 9/20 0.63
RAB9A P51151 8/20 0.63
NPC1 O15118 7/20 0.63
SMN1; SMN2 Q16637 7/20 0.63
ALDH1A1 P00352 7/20 0.63
MAPT P10636 6/20 0.61
TP53 P04637 2/20 0.61
LMNA P02545 7/20 0.58
CASP3 P42574 1/20 0.58
SENP8 Q96LD8 1/20 0.58
SENP7 Q9BQF6 1/20 0.58
SENP6 Q9GZR1 1/20 0.58
HCRTR1 O43613 1/20 0.57
KMT2A Q03164 2/20 0.56
MEN1 O00255 1/20 0.56
NFKB1 P19838 1/20 0.53
NFKB2 Q00653 1/20 0.53
RELA Q04206 1/20 0.53
POLB P06746 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4573000 1.00 KDM4E (0.63) KDM4EHPGDRAB9ANPC1SMN1; SMN2
SCHEMBL1356813 0.86 KDM4E (0.68) KDM4EHPGDRAB9ANPC1SMN1; SMN2
SCHEMBL1124345 0.86 KDM4E (0.68) KDM4EHPGDRAB9ANPC1SMN1; SMN2
SCHEMBL22708314 0.75 ALDH1A1 (0.50) KDM4EHPGDRAB9ANPC1SMN1; SMN2
SCHEMBL170156 0.72
SCHEMBL22412532 0.72 KDM4E (0.47) KDM4EHPGDRAB9ANPC1SMN1; SMN2
SCHEMBL22412533 0.72 KDM4E (0.47) KDM4EHPGDRAB9ANPC1SMN1; SMN2
SCHEMBL3456439 0.72 HPGD (0.51) KDM4EHPGDRAB9ANPC1SMN1; SMN2
SCHEMBL3456437 0.72 HPGD (0.51) KDM4EHPGDRAB9ANPC1SMN1; SMN2
SCHEMBL4574411 0.71 RAB9A (0.63) KDM4EHPGDRAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080267942-A1 BENZAZEPIN-2(1H)-ONE DERIVATIVES PFIZER LIMITED (GB) 2008-10-30 US disclosed
US-20080103130-A1 7-hydroxy-6-{[1-methyl-3-(1,3-thiazol-5-yl)propyl]amino}-4,5,6,7-tetrahydroimidazo[4,5,1-jk][1]benzazepin-2(1H)-one; agonists at the beta-2 adrenoceptor; feed additives for livestock animals; improving meat yield or meat quality PFIZER LIMITED (GB) 2008-05-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080103130-A1 7-hydroxy-6-{[1-methyl-3-(1,3-thiazol-5-yl)propyl]amino}-4,5,6,7-tetrahydroimidazo[4,5,1-jk][1]benzazepin-2(1H)-one; agonists at the beta-2 adrenoceptor; feed additives for livestock animals; improving meat yield or meat quality ADRB2, ADRB1, ADRA2C KDM4E 1178/4885HPGD 2989/4885RAB9A 4414/4885
US-20080267942-A1 BENZAZEPIN-2(1H)-ONE DERIVATIVES ADRB2, ADRB1, ADRA2C KDM4E 3904/4885HPGD 2323/4885RAB9A 3565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.